SCIENTIFIC PROGRAMME - EMPAG
Sunday, May 26, 2002

Saturday, May 25, 2002 - Monday, May 27, 2002 - Schedule

Time
Room
Session

08.45 -
10.45
Erasme
with ESHG

Plenary Session PS 3: Genetic testing in minors (together with ESHG)
Chair: D. Donnai and G. Evers-Kiebooms

PS07: From 12 years of neonatal CF testing in Brittany to the 2002 national French programme  (20')
C. Ferec (Brest)

PS08: Lessons from the Newborn Screening Programme in Wales  (20')
A. Clarke (Cardiff)

PS09: Predictive testing in minors  (30')
A. M. Codori, K. L. Zawacki, G. M. Petersen, D. L. Miglioretti, J. A. Bacon, J. D. Trimbath, S. V. Booker, K. Picarello, F. M. Giardiello, A. M. Codori;
Johns Hopkins Hospital, Baltimore, MD

PS10: Carrier Testing in Childhood: Conflict or Compromise?  (30')
C. Barnes;
Genetics Centre, Guy's & St. Thomas' Hospital Trust, London, UNITED KINGDOM

General Panel Discussion  (20')
 

10.45 -
11.15
Coffee/Poster viewing/Exhibition
11.15 -
12.30
Gutenberg
Concurrent Sessions

E-C 1 Screening Issues
Chair: T. Marteau

E-C01. Attitudes of Dutch general practitioners, pediatricians and gynecologists towards cystic fibrosis carrier screening  (15') 
M. J. H. Baars, L. Henneman, M. C. Cornel, L. P. Ten Kate;
VU University Medical Center, Amsterdam, NETHERLANDS. 

E-C02. Feasibility and acceptability of two screening strategies for haemochromatosis, report of phase one of a randomised controlled trial.  (15') 
C. Patch1, P. Roderick1, W. Rosenberg2;
1Health Care Research Unit, University of Southampton, Southampton, UNITED KINGDOM, 2Division of Inflammation, Infection and Repair, University of Southampton, Southampton, UNITED KINGDOM. 

E-C03. Coping strategies of pregnant women after "triple-diagnostic" and those of their partners  (15') 
S. Jahn, F. R. Kreuz;
Technical University, Dresden, GERMANY. 

E-C04. Serum screening uptake and attitudes towards Down's syndrome  (15')
L. D. Bryant, J. M. Green, J. Hewison;
University of Leeds, Leeds, UNITED KINGDOM. 
 

11.15 -
12.30
Kléber
E-C 2 Cultural and Ethical Issues
Chair: G. Wolff

E-C05. Thalassaemia carrier testing in pregnant Pakistani women: perceptions of ‘information’ and ‘consent’.  (15') 
S. Ahmed, J. Green, J. Hewison;
University of Leeds, Leeds, UNITED KINGDOM. 

E-C06. Breast cancer: South Asian patient's experience, attitudes, beliefs and perception of risk.  (15') 
G. A. Karbani;
Centre for Research in Primary Care, Leeds, UNITED KINGDOM. 

E-C06. Genetic Testing for Hearing Impairment- Different Motivations for the Same Outcome  (15') 
M. Sagi1, O. Dagan2, H. Hochner1, H. Levi3, A. Raas-Rothschild1, T. Cohen1;
1Department of Human Genetics Hadassah Hebrew University Hospital, Jerusalem, ISRAEL, 2Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, ISRAEL, 3Speech and Hearing Center, Hadassah Hebrew University Hospital, Jerusalem, ISRAEL. 

E-C08. Uses of the body and informed consent for participants in predictive medicine research  (15') 
P. Ducournau;
INSERM U558, Toulouse, FRANCE. 

E-C09. Am I My Brother’s Keeper?: Outlining Rights and Responsibilities in the Context of the Human Genome Diversity Project  (15') 
J. K. Brewer1,2;
1Harvard University, Cambridge, MA, 2De Paul College of Law, Chicago, IL. 

 

12.30 -
14.30
Poster Viewing/ Lunch
14.30 -
16.00
Gutenberg
E-C 3 Psychological Support, Family Issues and Impact of Genetic Disease
Chair: E. Sikkens

E-C10. A Pilot Project on Rehabilitation in Huntington's Disease: Three Years Experience in Italy.  (15') 
P. Zinzi1, G. Jacopini1, R. De Grandis2, G. Graziani2, S. Maceroni2, P. Zappata2, A. Bentivoglio3, M. Frontali4;
1Institute of Psychology C.N.R., Rome, ITALY, 2Home Care "Nova Salus", Trasacco, ITALY, 3Institute of Neurology UCSC, Rome, ITALY, 4Institute of Neurobiology and Molecular Medicine C.N.R., Rome, ITALY. 

E-C11. Communication with relatives about predictive genetic testing for cancer predisposition  (15') 
C. Foster1, M. Watson2, C. Moynihan1, A. Ardern-Jones2, R. Eeles2;
1The Institute of Cancer Research, Sutton, UNITED KINGDOM, 2Royal Marsden NHS Trust, London/Sutton, UNITED KINGDOM. 

E-C12. Myotonic Dystrophy and the marital relationship  (15')
A. Rotteveel, A. R. Wintzen, A. Tibben;
Leids Universitair Medisch Centrum, Leiden, NETHERLANDS. 

E-C13. Putting HD into words: exploring the virtual narratives of the Italian HD support group online.  (15') 
G. Jacopini1, P. Zinzi1, A. Cordi2;
1Institute of Psychology C.N.R., Rome, ITALY, 2A.I.C.H.-ROME, Rome, ITALY. 

E-C14. Adult Survivors of child sex abuse in the genetic counselling consultation  (15') 
C. A. Falconer;
St James University Hospital, Leeds, UNITED KINGDOM. 
 

14.30 -
16.00
Kléber
E-C4 Genetic Counselling for Hereditary Cancers
Chair: M. Decruyenaere

E-C15. Women at increased risk for breast cancer (BC) attending a regular surveillance program. Preliminary results of the baseline measurement.  (15') 
S. van Dooren1, C. Seynaeve2, H. J. Duivenvoorden1, M. Kriege2, A. J. Rijnsburger3, J. G. M. Klijn2, C. C. M. Bartels2, H. J. de Koning3, A. Tibben1;
1Department of Medical Psychology and Psychotherapy, Erasmus Medical Centre, Rotterdam, NETHERLANDS, 2Family Cancer Clinic/Daniel den Hoed Clinic, Erasmus Medical Centre, Rotterdam, NETHERLANDS, 3Department of Public Health, Erasmus Medical Centre, Rotterdam, NETHERLANDS. 

E-C16. The meaning of risk: Women's perceptions of the genetic risk of breast and ovarian cancer following BRCA1/2 mutation searching  (15') 
N. Hallowell1, C. Foster1, R. Eeles1, A. Ardern Jones2, V. Murday3, R. Houlston1, M. Watson4;
1Institute of Cancer Research, London, UNITED KINGDOM, 2Royal Marsden Hospital, London, UNITED KINGDOM, 3St George's Hospital, London, UNITED KINGDOM, 4The Royal Marsden Hospital, London, UNITED KINGDOM. 

E-C17. Women from HBOC families during the BRCA genetic testing process : lay and providers interactions  (15') 
C. M. Julian-Reynier1, C. Cypowyj1, F. Chabal1, F. Eisinger2, H. Sobol3;
1INSERM U379, Marseilles, FRANCE, 2INSERM U379 & E9939 & Institut Paoli-Calmettes, Marseilles, FRANCE, 3INSERM E9939 & Institut Paoli-Calmettes, Marseilles, FRANCE. 

E-C18. Theory of Engagement: A model for predictive test counselling  (15') 
M. McAllister1, A. Silver2, G. Evans3;
1Regional Genetics Service and Academic Group of Medical Genetics, Manchester, UNITED KINGDOM, 2Oxford Regional Genetics, Oxford, UNITED KINGDOM, 3Regional Genetics Service and Academic Group of Medical Genetics, St Mary's Hospital, Manchester, UNITED KINGDOM. 

E-C19. Impact of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC)  (15') 
J. L. Halliday1, B. Meiser2, R. Warren1, V. R. Collins1, C. Gaff3;
1Murdoch Childrens Research Institute, Victoria, AUSTRALIA, 2Prince of Wales Hospital, Randwick, AUSTRALIA, 3Genetic Health Services, Victoria, AUSTRALIA. 

E-C20. The influence of consultants’ communication and information-giving behaviours on patient outcomes: A multi centre study of genetic counselling with women from high risk breast cancer families  (15')
E. A. Lobb1, P. N. Butow1, B. Meiser2, A. Barratt3, C. Gaff4,5, M. A. Young6, E. Haan7, G. Southers7, M. Gattas8, K. Tucker9;
1Medical Psychology Research Unit, Department of Psychological Medicine, University of Sydney, Sydney, AUSTRALIA, 2Dept. of Psychological Medicine, Royal North Shore Hospital, St. Leonards, AUSTRALIA, 3Dept. of Public Health and Community Medicine, University of Sydney, Sydney, AUSTRALIA, 4Genetic Health Services Victoria, Royal Children’s Hospital, Parkville, AUSTRALIA, 5Royal Melbourne Hospital, Parkville, AUSTRALIA, 6Peter Mac Callum Cancer Institute, Melbourne, AUSTRALIA, 7South Australian Clinical Genetics Service, Women’s & Children’s Hospital, North Adelaide, AUSTRALIA, 8Queensland Clinical Genetics Service, Royal Children’s Hospital, Queensland, AUSTRALIA, 9Hereditary Cancer Clinic, Prince of Wales Hospital, Sydney, AUSTRALIA. 

 

16.30 -
18.00
Schumann
with ESHG
Concurrent Symposia

S 1 Cognition and Behaviour (together with ESHG)
Chair: D. Craufurd, D. Toniolo

S01. The study of behavioural phenotypes: implications for practice and management  (30')
A. Swillen, J. P. Fryns;
Center for Human Genetics, University Hospital Gasthuisberg, Leuven, BELGIUM.

S02. The tortuous path from genotype to phenotype: genes and cognition in mutant mice  (30')
H. P. Lipp;
Institute of Anatomy, University of Zurich, Zurich, SWITZERLAND

S03. Fragile X Syndrome - its impact on families  (30')
B. Carmichael;
Genetic Nurse Specialist, Southend Hospital, Westcliff on Sea, UNITED KINGDOM
 

16.30 -
18.00
Gutenberg
Workshop

E-W 1 "How broad are the patient's shoulders?
A different way of looking at patients and their questions in the intake session.
Organisers: B.A.W.Rozendal and H.G. van Spijker
 

19.30 Social Evening - Dinner Cruise

Saturday, May 27, 2002 - Monday, May 27, 2002 - Schedule